Search research articles
Contact Us
Filters
Showing results (61-70 of 297) with videos related to
Page
of 30
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
July 18, 2025
Reply to Zeng: Redefining Accelerated PH in IPF: Uncovering Treatment Effects and Novel Triggers
Steven D Nathan, Ho Cheol Kim, Christopher King, et al.
Expert Review of Respiratory Medicine
|
May 19, 2010
Potential of imatinib mesylate as a novel treatment for pulmonary fibrosis
Mantej Chhina, Oksana A Shlobin, Geraldine Grant, et al.
The European Respiratory Journal
|
May 7, 2026
ERJ Viewpoint: vascular targeted therapies for fibrotic lung disease - Start of a new era?
Albina Tyker, Laura C Price, Steven D Nathan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 12, 2003
Bronchiolitis obliterans syndrome: utility of the new guidelines in single lung transplant recipients
Steven D Nathan, Scott D Barnett, Julie Wohlrab, et al.
Journal of Clinical Medicine
|
March 27, 2025
Review of the Diagnosis and Management of Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH)
Zein Kattih, Ho Cheol Kim, Shambhu Aryal, et al.
The European Respiratory Journal
|
February 8, 2020
FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
Steven D Nathan, Ming Yang, Elizabeth A Morgenthien, et al.
Future Cardiology
|
December 18, 2009
Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension
Mantej K Chhina, Weir Nargues, Geraldine M Grant, et al.
Contemporary Clinical Trials
|
November 27, 2020
Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis
Lisa Lancaster, Ann Fieuw, Joyce Meulemans, et al.
Chest
|
July 8, 2015
Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions
Keith C Meyer, Sonye K Danoff, Lisa H Lancaster, et al.
Thorax
|
March 25, 2022
Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis
Abhimanyu Chandel, Jean Pastre, Solène Valery, et al.
Page
of 30
Search research articles
Search
Showing results (61-70 of 297) with videos related to
Sort By:
Page
of 30
American Journal of Respiratory and Critical Care Medicine
|
July 18, 2025
Reply to Zeng: Redefining Accelerated PH in IPF: Uncovering Treatment Effects and Novel Triggers
Steven D Nathan, Ho Cheol Kim, Christopher King, et al.
Expert Review of Respiratory Medicine
|
May 19, 2010
Potential of imatinib mesylate as a novel treatment for pulmonary fibrosis
Mantej Chhina, Oksana A Shlobin, Geraldine Grant, et al.
The European Respiratory Journal
|
May 7, 2026
ERJ Viewpoint: vascular targeted therapies for fibrotic lung disease - Start of a new era?
Albina Tyker, Laura C Price, Steven D Nathan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 12, 2003
Bronchiolitis obliterans syndrome: utility of the new guidelines in single lung transplant recipients
Steven D Nathan, Scott D Barnett, Julie Wohlrab, et al.
Journal of Clinical Medicine
|
March 27, 2025
Review of the Diagnosis and Management of Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH)
Zein Kattih, Ho Cheol Kim, Shambhu Aryal, et al.
The European Respiratory Journal
|
February 8, 2020
FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
Steven D Nathan, Ming Yang, Elizabeth A Morgenthien, et al.
Future Cardiology
|
December 18, 2009
Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension
Mantej K Chhina, Weir Nargues, Geraldine M Grant, et al.
Contemporary Clinical Trials
|
November 27, 2020
Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis
Lisa Lancaster, Ann Fieuw, Joyce Meulemans, et al.
Chest
|
July 8, 2015
Management of Idiopathic Pulmonary Fibrosis in the Elderly Patient: Addressing Key Questions
Keith C Meyer, Sonye K Danoff, Lisa H Lancaster, et al.
Thorax
|
March 25, 2022
Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis
Abhimanyu Chandel, Jean Pastre, Solène Valery, et al.
Page
of 30